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Effect on Renal Function of Restoration of Euthyroidism in
Hyperthyroid Cats with Iatrogenic Hypothyroidism
T.L. Williams, J. Elliott, and H.M. Syme
Background: Iatrogenic hypothyroidism is associated with an increased incidence of azotemia after treatment of hyper-
thyroidism, and decreased survival time in azotemic hyperthyroid cats.
Hypothesis: Restoration of euthyroidism will decrease plasma creatinine concentrations.
Animals: Nineteen client-owned, methimazole- or carbimazole-treated, hyperthyroid cats with documented iatrogenic
hypothyroidism (based on subnormal plasma total thyroxine concentrations [TT4] and increased plasma thyroid-stimulat-
ing hormone concentrations).
Methods: Prospective interventional study. Doses of antithyroid medication were reduced until euthyroidism was
restored (TT4 10–40 nmol/L). Plasma creatinine concentration and selected other clinicopathologic variables were evalu-
ated before and after restoration of euthyroidism and compared by nonparametric statistics. Data are presented as median
[25th, 75th percentile].
Results: Restoration of euthyroidism was associated with a significant decrease in plasma creatinine concentrations
(2.61 [1.90, 3.26] mg/dL versus 2.07 [1.42, 2.82] mg/dL; P < .001) and body weight (4.03 [3.59, 4.53] kg versus 3.89 [3.34,
4.18] kg; P = .019), and a significant increase in packed cell volume (30 [28, 39]% versus 34 [29, 39]%; P = .038), heart
rate (174 [163, 201] bpm versus 190 [164, 202] bpm; P = .009), and plasma alkaline phosphatase activity (26.6 [17.0, 33.0]
IU/L versus 38.0 [23.5, 46.5] IU/L; P < .001).
Conclusions and Clinical Importance: Restoration of euthyroidism in medically treated hyperthyroid cats with iatrogenic
hypothyroidism causes a reduction in plasma creatinine concentrations, and thus might improve renal function; however,
this could be influenced by concurrent changes in body weight.
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Iatrogenic hypothyroidism is associated with anincreased incidence of azotemia in hyperthyroid cats
after treatment.1 Thyroid hormone replacement treat-
ment is associated with an improvement in renal func-
tion in dogs with primary hypothyroidism2; however,
the effect of restoration of euthyroidism on renal func-
tion in cats with iatrogenic hypothyroidism has only
been investigated in 1 small previous study of cats that
had been treated with radioactive iodine, which demon-
strated no improvement in glomerular filtration rate
(GFR).3
The aim of the present prospective study was to
investigate the effect of restoration of euthyroidism on
renal function, and selected other clinicopathologic
variables, in a cohort of medically treated hyperthy-
roid cats with iatrogenic hypothyroidism.
Materials and Methods
Hyperthyroid cats receiving antithyroid medication (methimaz-
ole [n = 18] or carbimazole [n = 1]) with documented iatrogenic
hypothyroidism were prospectively recruited into the study at 2
London based 1st opinion practices (Peoples’ Dispensary for Sick
Animals, Bow and Beaumont Sainsbury Animal Hospital, Cam-
den) between July 2009 and October 2013. Blood samples were
collected with the informed consent of the owner. Iatrogenic
hypothyroidism was defined as a plasma total thyroxine (TT4)
<10 nmol/L in combination with plasma thyroid stimulating hor-
mone (TSH) >0.15 ng/mL (the upper limit of the reference inter-
val derived from 90 healthy geriatric cats in a previous study4).
The Ethics and Welfare Committee of the Royal Veterinary Col-
lege approved the diagnostic protocol. Jugular venous blood
samples were collected and transferred to heparinized tubes. Sam-
ples were kept at 4°C before processing which occurred within
6 hours of collection. Blood samples were placed in a centrifuge
at 2016 9 g for 10 minutes to enable separation of plasma from
cellular components. Heparinized plasma was submitted to an
external laboratorya for routine biochemical analysis (including
TT4 concentration). Plasma creatinine concentrations were mea-
sured by using the Jaffe (picric acid) method and plasma total
thyroxine concentrations were determined by using the Immulite
chemiluminescent assay as validated for use in cats previously.5,6
Plasma TSH concentrations were measured at the Royal Veteri-
nary College laboratoryb by using the Immulite canine TSH
assay (Siemens, Camberley, UK) as previously validated.7
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Systolic blood pressure (SBP) measurements were made with an
8.1 MHz Doppler ultrasound probe according to the protocol
previously described.8
After confirmation of iatrogenic hypothyroidism, dose reduc-
tions were made in 1.25 mg average daily methimazole dose
increments (usually by reducing the dose in 2.5 mg methimazole
every other day increments) every 4 weeks until euthyroidism
was established (plasma TT4 between 10 and 40 nmol/L). During
the study period, no new medications or diets were instituted and
the doses of all existing medications (except antithyroid medica-
tion) were not changed. Body weight, body condition score
(BCS), SBP, packed cell volume (PCV), heart rate (HR), and
plasma concentrations of urea, creatinine, cholesterol, total cal-
cium and plasma activities of alanine aminotransferase (ALT)
and alkaline phosphatase (ALP) were recorded at baseline and
once euthyroidism was achieved.
Statistical Analysis
Continuous data are presented as median [25th, 75th percen-
tile]. Clinicopathologic parameters were compared at baseline
and after restoration of euthyroidism using the Wilcoxon signed
rank test. Correlations were made using Spearman’s correlation
coefficient. Statistical significance was defined as P < .05.
Results
Nineteen cats with iatrogenic hypothyroidism were
recruited into the study. Baseline plasma TT4 and
TSH concentrations were <4.0 [<4.0, 4.8] nmol/L and
4.3 [0.9, 7.2] ng/mL, respectively. At baseline, 14/19
cats (74%) were azotemic (defined as plasma creati-
nine concentration >2 mg/dL [the upper reference
limit for creatinine at the external laboratorya]). Three
of these cats were azotemic before or at the time of
diagnosis of hyperthyroidism. The reference limits for
plasma creatinine concentration were determined by
the external laboratorya in an internal unpublished
study (Federico Sacchini, personal communication).
Urine specific gravity (USG) was <1.035 in 8 of the
azotemic cats (consistent with renal azotemia). In the
other 6 azotemic cats, concurrent USG measurement
was not performed (as the cats did not have a palpa-
ble bladder). Five cats had a plasma creatinine
>250 lmol/L (the lower limit of IRIS stage 3) and 14
cats had plasma creatinine concentrations between 177
and 249 lmol/L. The average daily methimazole dose
given to cats at the hypothyroid visit was 5 [5, 7.5]
mg.
Euthyroidism was established 32 [28, 68] days
(maximum 218 days) after diagnosis of iatrogenic
hypothyroidism and required a dose adjustment of
2.5 [1.25, 2.5] mg methimazole (or methimazole
equivalent) daily. Eight cats required every other day
dosing. The average daily methimazole dose given to
cats after restoration of euthyroidism was 3.75 [2.5,
5] mg. Plasma TT4 concentration after dose adjust-
ment was 20.8 [14.7, 26.1] nmol/L. Plasma TSH con-
centrations were not determined after restoration of
euthyroidism. Restoration of euthyroidism resulted in
a significant decrease (median 20.7%) in plasma cre-
atinine concentration (Fig 1), and azotemia resolved
in 7/14 cats (50%). After restoration of euthyroid-
ism, 3 cats had a plasma creatinine concentration
>250 lmol/L (the lower limit of IRIS stage 3), 2 of
which had concentrations >250 lmol/L at the hypo-
thyroid visit, and all other cats had plasma creati-
nine concentrations between 140 and 249 lmol/L
(corresponding to lower and upper limits of IRIS
stage 2). Restoration of euthyroidism also resulted in
a significant increase in plasma ALP activity, HR,
and PCV, and a significant decrease in body weight
(Table 1). No significant changes in BCS, SBP,
plasma concentrations of urea, cholesterol, total cal-
cium, or plasma ALT activity were observed after
restoration of euthyroidism (Table 1). Plasma creati-
nine concentrations were not correlated (P > .05)
with body weight or TT4 at either the hypothyroid
or euthyroid visits.
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Fig 1. Change in plasma creatinine concentration before and
after establishment of euthyroidism in 19 cats with iatrogenic
hypothyroidism. Dotted line represents the upper limit of the lab-
oratorya reference interval for plasma creatinine concentration
(2 mg/dL). Change in plasma creatinine concentration between
the hypothyroid and euthyroid visits was assessed by Wilcoxon
signed rank test with statistical significance defined as P < .05.
Plasma creatinine concentration decreased significantly after res-
toration of euthyroidism (P < .001).
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Discussion
The aim of the present study was to assess the effect
of restoring euthyroidism on renal function, using
plasma creatinine concentration as a marker of GFR.
Thyroid hormone replacement therapy is associated
with an improvement in renal function in canine
patients with primary hypothyroidism2; however, 1
small previous study reported that restoration of euthy-
roidism in radioiodine-treated cats with iatrogenic
hypothyroidism and azotemia did not improve GFR.3
In the present study, restoration of euthyroidism in cats
with iatrogenic hypothyroidism resulted in a decrease
in plasma creatinine concentrations in 18 of 19 cats,
and resolution of azotemia in 50% of hypothyroid azo-
temic cats. However, restoration of euthyroidism also
resulted in a significant decrease in body weight; there-
fore, if this was also associated with a reduction in
body muscle mass, this could account for the reduction
in plasma creatinine concentrations. Body condition
score was recorded in the present study, and did not
change significantly after restoration of euthyroidism;
however, specific muscle condition scoring systems are
currently being developed and validated, which might
be a more sensitive indicator of changes in body muscle
mass. These could be incorporated into future studies
to assess the changes in muscle mass that occur after
restoration of euthyroidism in cats with iatrogenic
hypothyroidism. However, it is likely that these scoring
methods will always be insensitive to small changes and
hampered by interindividual variability in assessment,
making it difficult to detect changes in body weight and
body muscle mass accurately.
In addition, dogs with experimentally induced hypo-
thyroidism have reduced GFR without significant
increases in plasma creatinine concentration, perhaps
because of a reduction in endogenous creatinine pro-
duction.9 Therefore, it could be hypothesized that iat-
rogenic hypothyroidism in cats might also result in
decreased endogenous creatinine production, which in
turn might cause an overestimation of GFR (based on
plasma creatinine concentrations) in these cats. Hence,
the severity of renal dysfunction in iatrogenic hypothy-
roidism might have been underestimated in the present
study. Direct measurement of GFR would be required
to determine the true degree of renal dysfunction in
cats with iatrogenic hypothyroidism, and to determine
if renal function improved after restoration of euthy-
roidism; however, this was not performed in the pres-
ent study.
In the present study, renal azotemia (defined as doc-
umentation of an increased plasma creatinine concen-
tration and concurrent USG <1.035) was only
confirmed in 8/14 azotemic cats; therefore, the pres-
ence of prerenal azotemia, which could have been tran-
sient, cannot be excluded in the remaining 6 azotemic
cats. Nevertheless, plasma creatinine concentrations
decreased after restoration of euthyroidism in all 8 cats
with confirmed renal azotemia and 18/19 cats in the
entire study cohort; therefore it is unlikely that the
presence of transient prerenal azotemia could account
for the observed changes in plasma creatinine concen-
trations after restoration of euthyroidism.
Previous studies have reported that up to 49% of
initially nonazotemic hyperthyroid cats will develop
azotemic CKD after treatment,10 which has led to the
Table 1. Selected clinicopathologic variables before and after establishment of euthyroidism in 19 cats with iatro-
genic hypothyroidism. N/A, not applicable. Wilcoxon signed rank test was used to compare variables between the
hypothyroid and euthyroid visits. Variables highlighted in bold were significantly different between the 2 visits
(P < .05).
Variable
Laboratorya
Reference Interval
Hypothyroid Visit Euthyroid Visit
P-Value
Median [25th,
75th Percentile]
Median [25th,
75th Percentile]
Plasma urea
concentration (mg/dL)
15.1–59.6 42.3 [37.2, 57.1] 43.4 [31.4, 64.7] .19
Plasma creatinine
concentration (mg/dL)
0.22–2.00 2.61 [1.90, 3.26] 2.07 [1.42, 2.82] <.001
Plasma alanine
aminotransferase
activity (IU/L)
5.0–60.0 74.7 [42.7, 85.6] 69.6 [52.1, 135.8] .077
Plasma alkaline
phosphatase activity (IU/L)
<60.0 26.6 [17.0, 33.0] 38.0 [23.5, 46.5] <.001
Plasma cholesterol
concentration (mg/dL)
85.1–154.7 189.2 [166.0, 281.9] 200.8 [146.7, 247.1] .47
Plasma total calcium
concentration (mg/dL)
8.2–11.8 10.6 [10.0, 11.6] 10.4 [9.9, 11.1] .14
Packed cell volume (%) 26–45 30 [28, 39] 34 [29, 39] .038
Body weight (kg) N/A 4.03 [3.59, 4.53] 3.89 [3.34, 4.18] .019
Body condition score (/9) N/A 4 [3, 5] 5 [3, 6] .37
Mean systolic blood
pressure (mmHg)
N/A 130.6 [122.0, 140.7] 135.4 [129.8, 140.7] .81
Heart rate (bpm) N/A 174 [163, 201] 190 [164, 212] .009
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suggestion that hyperthyroid cats could be at increased
risk of developing CKD. However, the results of the
present study confirm that iatrogenic hypothyroidism is
likely to increase plasma creatinine concentration and
thus may have overexaggerated the prevalence of azo-
temic CKD in hyperthyroid cats in previous studies.
Restoration of euthyroidism resulted in a significant
increase in PCV and HR of cats in the present study.
These findings suggest that iatrogenic hypothyroidism
has a negative effect on hematopoietic function, result-
ing in a reduction in red cell mass, and a concurrent
negative effect on cardiovascular function, that
together might increase morbidity (and thus perhaps
mortality) in cats with iatrogenic hypothyroidism.
Human patients with hypothyroidism are reported to
have a macrocytic hypochromic anemia, which is asso-
ciated with a reduced proliferative potential of hema-
topoietic stem cells.11 It is possible that a similar
pathophysiologic mechanism could account for the
reduced PCV that was observed in hypothyroid cats in
the present study; however, further studies would be
required to confirm this.
Hypothyroid azotemic cats have reduced survival
times compared to hypothyroid nonazotemic cats,1
therefore it could be postulated that dose adjustments
of antithyroid medication to restore euthyroidism will
also improve the survival times of hypothyroid azo-
temic cats. Thyroid hormone replacement treatment in
human patients with subclinical hypothyroidism atten-
uates the decline in renal function of patients with
CKD,12 and could therefore also attenuate the decline
in renal function in cats with iatrogenic hypothyroid-
ism and CKD, thus perhaps increasing the survival
time of these cats. However, it has also been suggested
that mild hypothyroidism might be a beneficial adapta-
tion in human patients with CKD, as hypothyroidism
will lead to reduced protein nitrogen turnover and pro-
tein catabolism and hence reduced nitrogenous waste
load for the kidney to excrete.13 Interestingly, plasma
urea concentration did not decrease after restoration
of euthyroidism in the present study, despite a concur-
rent significant reduction in plasma creatinine concen-
trations. This could suggest that iatrogenic
hypothyroidism results in a decreased protein nitrogen
turnover in cats, which could be beneficial in cats with
CKD, although this beneficial effect is likely to be
minimal. Alternatively, the lack of reduction in plasma
urea concentrations despite a reduction in plasma cre-
atinine concentrations could suggest that the reduction
in plasma creatinine concentrations was secondary to
changes in body weight and body muscle mass rather
than changes in GFR. To improve the survival times
of cats with CKD, the effect of decreasing nitrogenous
waste load in the hypothyroid state would have to be
more beneficial than the increase in GFR that would
be associated with restoration of the euthyroid state.
Prospective randomized, controlled, interventional
studies would be required to evaluate the long-term
survival of azotemic cats with iatrogenic hypothyroid-
ism after restoration of euthyroidism; however, they
were not performed in the present study as it was not
felt to be ethically justifiable to not adjust the dose of
antithyroid medication given to some client-owned
azotemic cats with iatrogenic hypothyroidism in light
of the current available data.1 Nevertheless, these stud-
ies would be required to definitively prove that restora-
tion of euthyroidism results in improved survival times
in azotemic cats with iatrogenic hypothyroidism.
Corrections made after online publication April 28, 2014: cita-
tions in the final paragraph of the Discussion section have been
updated.
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